TerrAscend to Participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference

TerrAscend leadership plans one-on-one meetings with institutional investors at a New York life sciences conference in September 2026.

Rhea-AI Summary

TerrAscend (TSNDF) will participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference in New York City on September 9, 2026.

Executive Chairman Jason Wild and CEO Ziad Ghanem will host one-on-one meetings with institutional investors throughout the event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference held in New York City, on September 9, 2026. Jason Wild, Executive Chairman and Ziad Ghanem, Chief Executive Officer, will host one-on-one meetings throughout the conference.

About TerrAscend Corp.
TerrAscend Corp. is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One and Valhalla. For more information visit www.terrascend.com.

For more information regarding the Company:
Eric Jackson
Chief Financial Officer
IR@terrascend.com
614-783-6506

Investor Relations Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
TerrAscend@KCSA.com
212-896-1254

FAQ

When will TerrAscend (TSNDF) attend the ATB Cormark 2026 Life Sciences Fall Institutional Investor Conference?

TerrAscend will participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference in New York City on September 9, 2026.

Which TerrAscend (TSNDF) executives are attending the ATB Cormark 2026 Life Sciences conference?

TerrAscend states that Executive Chairman Jason Wild and Chief Executive Officer Ziad Ghanem will attend and host one-on-one meetings throughout the conference.

What will TerrAscend (TSNDF) management do at the ATB Cormark 2026 investor conference?

At the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference, TerrAscend’s executive management team plans to host one-on-one meetings with institutional investors.

Where is the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference taking place for TerrAscend (TSNDF)?

The ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference that TerrAscend will attend is scheduled to be held in New York City.

Who is the investor relations contact for TerrAscend (TSNDF) regarding this conference?

TerrAscend lists Eric Jackson, Chief Financial Officer, at IR@terrascend.com and 614-783-6506, and KCSA Strategic Communications’ Valter Pinto at TerrAscend@KCSA.com and 212-896-1254 for investor relations inquiries.